http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012130720-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_029ae7705ae5d12790827b4c7f5249e9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2b4b473471b6e5770d5c69d2c320d112
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bae91fbffaa014dddcf2d83cb4a992a4
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
filingDate 2012-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc11074aa23dc8acf877d76e46f29410
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8379c79d79f6155ea4a0847810cb3d37
publicationDate 2012-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2012130720-A3
titleOfInvention PREDICTION OF RESPONSIVENESS TO PIK3/mTOR INHIBITORS
abstract A method for determining the responsiveness of a mammalian tumor cell to treatment with an inhibitor of the phosphoinosite 3-kinase (PI3K) and/or mammalian target of rapamycin (mTOR) pathway, said method comprising determining the c-MYC and/or NOTCH1 level in said tumor cell, wherein said level is indicative of whether the cell is likely to respond or is responsive to the treatment. It further refers to an in vitro method for the identification of a resistance to treatment or of predicting or monitoring the efficacy of treatment, of solid tumor cancer with an inhibitor of the PI3K and/or mTOR pathway in a patient suffering from said cancer. It further refers to a combination comprising an amount of an inhibitor of the PI3K and/or mTOR pathway, and an amount of a c-MYC and/or NOTCH 1 inhibitor.
priorityDate 2011-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009039457-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009103790-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010030865-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006122053-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010040124-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395632
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284616

Total number of triples: 23.